NCT01607333View on ClinicalTrials.gov

WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Epilepsy

Interventions

DRUG

Lamotrigine use

Lamotrigine prescription during the study period

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01607333 - WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide | Biotech Hunter | Biotech Hunter